Published in Pharma Law Weekly, March 21st, 2006
According to recent research from Austria, "The human placenta is a complex organ situated at the interface between mother and fetus that separates maternal from fetal blood. The placental surfaces exposed to the two bloodstreams are different, i.e. trophoblasts and endothelial cells are in contact with the maternal and fetal circulation, respectively. Both cell types produce high insulin receptor levels."
U. Hiden and colleagues working with the Medical University of Graz proposed "to test the hypothesis that spatio-temporal changes in insulin...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly